Skip to main content

Table 3 Odds ratio (OR) and 95% confidence interval (CI) for DCIS upgraded to invasive disease

From: Selective omission of sentinel lymph node biopsy in mastectomy for ductal carcinoma in situ: identifying eligible candidates

Variables

Univariable

Multivariable

OR (95% CI)

p-value

OR (95% CI)

p-value

Age (years)

    

 > 50

Ref.

 

Ref.

 

 ≤ 50

0.78 (0.52–1.17)

0.234

1.01 (0.58–1.76)

0.964

Palpable mass or bloody nipple discharge

    

 No

Ref.

 

Ref.

 

 Yes

2.67 (1.76–4.05)

< 0.001

2.76 (1.64–4.64)

< 0.001

Clinical tumor size, median (range), cm

1.26 (1.14–1.39)

< 0.001

1.20 (1.06–1.35)

0.003

Suspicious axillary lymph node on radiologic evaluation

    

 No

Ref.

 

Ref.

 

 Yes

2.31 (1.43–3.74)

0.001

2.01 (1.08–3.74)

0.028

Suspicious microcalcification on radiologic evaluation

    

 No

Ref.

 

Ref.

 

 Yes

1.27 (0.81–1.97)

0.296

1.43 (0.79–2.58)

0.232

Nuclear grade*,†

 

0.042

 

0.270

 Low

Ref.

 

Ref.

 

 Intermediate

1.20 (0.64–2.27)

0.566

0.72 (0.31–1.68)

0.454

 High

2.16 (1.07–4.36)

0.032

1.21 (0.42–3.46)

0.720

Comedo necrosis*,†

    

 No

Ref.

 

Ref.

 

 Yes

1.42 (0.88–2.29)

0.153

0.86 (0.45–1.66)

0.662

Hormone receptor§

    

 Negative

Ref.

 

Ref.

 

 Positive

0.50 (0.31–0.79)

0.003

0.69 (0.31–1.54)

0.368

HER2§

    

 Negative

Ref.

 

Ref.

 

 Positive

1.44 (0.94–2.22)

0.093

0.69 (0.32–1.46)

0.326

Ki-67 (%) §

    

 < 14%

Ref.

 

Ref.

 

 ≥ 14%

2.45 (1.55–3.88)

< 0.001

1.55 (0.82–2.93)

0.182

  1. *Missing values
  2. †Values assessed in biopsy specimens
  3. §Values assessed in surgical specimens